Not Signed In -
Osteoporosis |
Bone Loss |
Clinical Trial: Pseudodrynaria Coronana (Wall) Ching
This study is currently recruiting patients.
Verified by National Taiwan University Hospital January 2000
|
Purpose
The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.
| Condition | Intervention | Phase |
|---|---|---|
| Osteoporosis | Drug: GUSUIBU | Phase I |
MedlinePlus related topics: Osteoporosis
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Official Title: Clinical Effect of Traditional Chinese Medicine - "Gusuibu"
Further Study Details:
Primary Outcomes: one year
Expected Total Enrollment: 120
Expected Total Enrollment: 120
Study start: January 2000; Expected completion: December 2003
Last follow-up: January 2001; Data entry closure: July 2002
Research of the this traditional chinese medicine clinucal, Gusuibu, curative effect is plan three years time. The entire studyaims to evaluated the effect of the traditional chinese medicine on postmenpausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal woman with established osteoporosis.
Eligibility
Ages Eligible for Study: 45 Years - 70 Years, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- postmenopausal osteoporosis
Exclusion Criteria:
- Insulin dependent diabetes
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00155675
Liu Hwa-Chang, M.D 886-2-23956988 hcliu@ha.mc.ntu.edu.tw
Taiwan, 7, Chung-Shan S. Road
National Taiwan University Medical Center, Taipei, 7, Chung-Shan S. Road, 100, Taiwan; Recruiting
Liu Hwa-Chang, M.D 886-2-23956988 hcliu@ha.mc.ntu.edu.tw
Study chairs or principal investigators
Liu Hwa-Chang, M.D, Study Chair, National Taiwan University Medical Center
More Information
Study ID Numbers: 900505; CCMP90-RD-114
Last Updated: September 9, 2005
Record first received: September 9, 2005
ClinicalTrials.gov Identifier: NCT00155675
Health Authority: Taiwan: Department of Health
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 9, 2005
Record first received: September 9, 2005
ClinicalTrials.gov Identifier: NCT00155675
Health Authority: Taiwan: Department of Health
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
